Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday. Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares climbed 46.4% to close at $0.3750 on Friday.
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day ex

Nasdaq Tumbles Over 200 Points; Crude Oil Drops Sharply

04:15pm, Friday, 23'rd Sep 2022 Benzinga
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping more than 200 points on Friday. The Dow traded down 1.53% to 29,615.88 while the NASDAQ fell 1.95% to 10,850.82. The
Shares of Cassava Sciences (NASDAQ: SAVA ) are down by over 15% following the previous day's gain of 35%. Yesterday, the Securities and Exchange Commission (SEC) announced that it had closed its case

US Stocks Open Lower; Dow Tumbles 400 Points

02:11pm, Friday, 23'rd Sep 2022 Benzinga
U.S. stocks traded lower this morning, with the Dow Jones dropping around 400 points on Friday. Following the market opening Friday, the Dow traded down 1.34% to 29,673.72 while the NASDAQ fell 1.96%
Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) shares jumped 167.7% to close at $2.20 on Thursday after the company announced it has entered into an exclusive license agreement with GSK for Spero's

Dow Turns Higher; Crude Oil Rises 0.7%

07:10pm, Thursday, 22'nd Sep 2022 Benzinga
U.S. stocks pared some losses, with the Dow Jones turning higher toward the end of trading on Thursday. The Dow traded up 0.09% to 30,211.16 while the NASDAQ fell 1% to 11,107.18. The S&P 500 also fe
Initiation of a phase 3 program open-label extension study using Simufilam for patients with Alzheimer's Disease is expected in 2nd half of 2022. An ongoing long-term open label study, initiated in Ma
Deleted: Despite a significant down day for the S&P 500, shares of Cassava Sciences (NASDAQ: SAVA ) closed higher by 35%. That's because the Securities and Exchange Commission (SEC) has closed its cas
Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 150% to $2.0508 after the company announced it has entered into an exclusive license agreement with GSK for Spero's late-stage antibiotic asset, t
The SEC reportedly cleared an investigation into Cassava Sciences, leading SAVA stock to hit a seven-month high Thursday. The post Cassava Skyrockets After SEC Clears It Of Tampering With Alzheimer's
U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording gains in today’s session. Albireo Pharma, Inc. (NASDAQ: ALBO) surged 13% to $

The SEC Has Officially Cleared Cassava Sciences

08:00am, Thursday, 22'nd Sep 2022
Cassava Sciences increased by over 10% intraday on positive SEC news. Cassava Sciences is up 26% in the last month while the market is down 7%.

What Is Going on With Cassava (SAVA) Stock Today?

09:36am, Wednesday, 21'st Sep 2022
Cassava Sciences (NASDAQ: SAVA ) stock rose nearly 30% on Sept. 20 as speculators bet on the company's efforts against Alzheimer's Disease.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE